Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Optimizing seizure control in Dravet syndrome: Cannabidiol or clobazam? | Synapse
March 3, 2026
Optimizing seizure control in Dravet syndrome: Cannabidiol or clobazam?
LF
Larissa Da Silva Falcão
NF
Nathália Figuerêdo
MA
Maria Cecília Assis Araújo
Ver todo
Puntos clave
Cannabidiol treatment improves seizure control in Dravet syndrome, indicating effective management options.
Participants experienced up to 50% reduction in seizure frequency with cannabidiol treatment.
Observational analysis of seizure outcomes across various reported cases reveals significant variability based on treatment.
This study highlights the need for more targeted research on optimizing seizure management in Dravet syndrome.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Falcão et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75f18c6e9836116a2a3f8
https://doi.org/https://doi.org/10.1016/j.jns.2025.123901